Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1 alpha,25-dihydroxyvitamin D analogues, diastereomeric at C17 and C20
Xm. Zhou et al., Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1 alpha,25-dihydroxyvitamin D analogues, diastereomeric at C17 and C20, J MED CHEM, 42(18), 1999, pp. 3539-3556
The synthesis of four CD-ring-modified 19-nor-1 alpha,25-dihydroxyvitamin D
g derivatives lacking C15, referred to as 6C analogues, and diastereomeric
at C17 and C20 is described. The synthesis involves an Ireland-Claisen rear
rangement of a 3-methyl-substituted ester of(1R)-3-methyl-2-cyclohexen-1-ol
as the key step, followed by elaboration of the side chain, transformation
into a C8 cyclohexanone derivative, and final Wittig-Horner coupling with
the 19-nor A-ring phosphine oxide. Despite possessing a more flexible side
chain than the parent hormone, biological evaluation showed an unexpected s
uperagonistic antiproliferative and prodifferentiating activity (10-50 time
s higher as compared to that of 1 alpha,25(OH)(2)D-3) for the diastereomer
with the "natural" configuration at C17 and C20. The other diastereomers ex
hibit a 25-90% decrease in activity. All four analogues show a decreased bi
nding affinity (45% or less), and their calcemic activity is 4-400 times le
ss than that of 1 alpha,25(OH)(2)D-3. The conformational behavior of their
side chain was studied using molecular mechanics calculations, and the resu
lt is presented as volume maps. A relative activity volume was determined b
y subtraction of the volume map of the least active analogue from the volum
e map of the most active one. This shows three regions corresponding to pre
ferred orientations in space of the side chain of the active analogue. One
of these regions was found to overlap with the region that is preferentiall
y occupied by the most active of the four diastereomeric 22-methyl-substitu
ted 1 alpha,25(OH)(2)D-3 analogues.